Lapatinib 68180-0801
Product NDC
68180-0801- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 29, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA203007
Need to source Lapatinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lapatinib Ditosylate | 250 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Packaging Options(1)
150 TABLET in 1 BOTTLE (68180-801-36)